Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

466 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Transthyretin Amyloidosis Cardiomyopathy in Greece: Clinical Insights from the National Referral Center.
Bampatsias D, Theodorakakou F, Briasoulis A, Georgiopoulos G, Dimoula A, Papantoniou V, Papantoniou I, Skiadaresi C, Valsamaki P, Repasos E, Petropoulos I, Delialis D, Papathoma A, Koutsis G, Tselegkidi ME, Stamatelopoulos K, Kastritis E. Bampatsias D, et al. Among authors: kastritis e. Hellenic J Cardiol. 2023 Oct 5:S1109-9666(23)00190-2. doi: 10.1016/j.hjc.2023.09.019. Online ahead of print. Hellenic J Cardiol. 2023. PMID: 37805173 Free article.
Amyloid-beta (1-40) and the risk of death from cardiovascular causes in patients with coronary heart disease.
Stamatelopoulos K, Sibbing D, Rallidis LS, Georgiopoulos G, Stakos D, Braun S, Gatsiou A, Sopova K, Kotakos C, Varounis C, Tellis CC, Kastritis E, Alevizaki M, Tselepis AD, Alexopoulos P, Laske C, Keller T, Kastrati A, Dimmeler S, Zeiher AM, Stellos K. Stamatelopoulos K, et al. Among authors: kastritis e. J Am Coll Cardiol. 2015 Mar 10;65(9):904-16. doi: 10.1016/j.jacc.2014.12.035. J Am Coll Cardiol. 2015. PMID: 25744007 Free article.
Clinical and prognostic significance of serum levels of von Willebrand factor and ADAMTS-13 antigens in AL amyloidosis.
Kastritis E, Papassotiriou I, Terpos E, Roussou M, Gavriatopoulou M, Komitopoulou A, Skevaki C, Eleutherakis-Papaiakovou E, Pamboucas C, Psimenou E, Manios E, Giannouli S, Politou M, Gakiopoulou H, Papadopoulou E, Stamatelopoulos K, Tasidou A, Dimopoulos MA. Kastritis E, et al. Blood. 2016 Jul 21;128(3):405-9. doi: 10.1182/blood-2016-02-702696. Epub 2016 May 10. Blood. 2016. PMID: 27166361 Free article. Clinical Trial.
Cardiac and renal complications of carfilzomib in patients with multiple myeloma.
Dimopoulos MA, Roussou M, Gavriatopoulou M, Psimenou E, Ziogas D, Eleutherakis-Papaiakovou E, Fotiou D, Migkou M, Kanellias N, Panagiotidis I, Ntalianis A, Papadopoulou E, Stamatelopoulos K, Manios E, Pamboukas C, Kontogiannis S, Terpos E, Kastritis E. Dimopoulos MA, et al. Among authors: kastritis e. Blood Adv. 2017 Feb 27;1(7):449-454. doi: 10.1182/bloodadvances.2016003269. eCollection 2017 Feb 28. Blood Adv. 2017. PMID: 29296960 Free PMC article.
Hereditary systemic amyloidosis caused by K19T apolipoprotein C-II variant.
Liapis K, Panagopoulou P, Charitaki E, Rowczenio D, Gilbertson J, Papathoma A, Kostopoulou M, Dimopoulos MA, Gillmore JD, Kastritis E. Liapis K, et al. Among authors: kastritis e. Amyloid. 2019 Mar;26(1):52-53. doi: 10.1080/13506129.2018.1562442. Epub 2019 Jan 26. Amyloid. 2019. PMID: 30686043 No abstract available.
Reactive Vasodilation Predicts Mortality in Primary Systemic Light-Chain Amyloidosis.
Stamatelopoulos K, Georgiopoulos G, Athanasouli F, Nikolaou PE, Lykka M, Roussou M, Gavriatopoulou M, Laina A, Trakada G, Charakida M, Delialis D, Petropoulos I, Pamboukas C, Manios E, Karakitsou M, Papamichael C, Gatsiou A, Lambrinoudaki I, Terpos E, Stellos K, Andreadou I, Dimopoulos MA, Kastritis E. Stamatelopoulos K, et al. Among authors: kastritis e. Circ Res. 2019 Sep 27;125(8):744-758. doi: 10.1161/CIRCRESAHA.119.314862. Epub 2019 Aug 12. Circ Res. 2019. PMID: 31401949 Free PMC article.
Primary treatment of light-chain amyloidosis with bortezomib, lenalidomide, and dexamethasone.
Kastritis E, Dialoupi I, Gavriatopoulou M, Roussou M, Kanellias N, Fotiou D, Ntanasis-Stathopoulos I, Papadopoulou E, Ziogas DC, Stamatelopoulos K, Manios E, Ntalianis A, Eleutherakis-Papaiakovou E, Papanikolaou A, Migkou M, Papanota AM, Gakiopoulou H, Psimenou E, Tselegkidi MI, Tsitsilonis O, Kostopoulos I, Terpos E, Dimopoulos MA. Kastritis E, et al. Blood Adv. 2019 Oct 22;3(20):3002-3009. doi: 10.1182/bloodadvances.2019000147. Blood Adv. 2019. PMID: 31648323 Free PMC article.
Solid Organ Transplantation in Amyloidosis.
Theodorakakou F, Fotiou D, Dimopoulos MA, Kastritis E. Theodorakakou F, et al. Among authors: kastritis e. Acta Haematol. 2020;143(4):352-364. doi: 10.1159/000508262. Epub 2020 Jun 12. Acta Haematol. 2020. PMID: 32535598 Free article. Review.
Upfront Daratumumab With Lenalidomide and Dexamethasone for POEMS Syndrome.
Gavriatopoulou M, Ntanasis-Stathopoulos I, Fotiou D, Migkou M, Eleutherakis-Papaiakovou E, Kanellias N, Roussou M, Dialoupi I, Malandrakis P, Theodorakakou F, Kastritis E, Terpos E, Dimopoulos MA. Gavriatopoulou M, et al. Among authors: kastritis e. Hemasphere. 2020 May 21;4(3):e381. doi: 10.1097/HS9.0000000000000381. eCollection 2020 Jun. Hemasphere. 2020. PMID: 32647800 Free PMC article. No abstract available.
Timing and impact of a deep response in the outcome of patients with systemic light chain (AL) amyloidosis.
Kastritis E, Fotiou D, Theodorakakou F, Dialoupi I, Migkou M, Roussou M, Karatrasoglou EA, Tselegkidi MI, Ntalianis A, Kanellias N, Eleutherakis-Papaiakovou E, Ntanasis-Stathopoulos I, Gakiopoulou C, Papanikolaou A, Papathoma A, Spyropoulou-Vlachou M, Psimenou E, Stamatelopoulos K, Gavriatopoulou M, Terpos E, Dimopoulos MA. Kastritis E, et al. Amyloid. 2021 Mar;28(1):3-11. doi: 10.1080/13506129.2020.1798224. Epub 2020 Jul 27. Amyloid. 2021. PMID: 32713209
466 results